← Back to Search

Tracheostomy Weaning Protocol for Intensive Care Patients (DECAP-ICU Trial)

N/A

Waitlist Available

Research Sponsored by Université de Sherbrooke

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, average of 6 to 12 months.

Awards & highlights

DECAP-ICU Trial Summary

This trial will test a new weaning tracheostomy technique to see if it can help patients wean off intubation faster than traditional method.

Who is the study for?

This trial is for patients in the ICU who have been weaned off mechanical ventilation for at least a day and are ready within 24 hours to try decannulation. It's not suitable for those with severe conditions like a high Sabadell score, low Glasgow Coma Scale, blocked airways, long-term tracheostomy needs, serious swallowing issues, or certain neuromuscular diseases.Check my eligibility

What is being tested?

The DECAP-ICU trial compares two methods of removing tracheostomy tubes: one based on how often suctioning is needed (new technique) versus the usual way which relies on how well patients tolerate having their tube capped.See study design

What are the potential side effects?

Potential side effects may include discomfort during suctioning or capping procedures, breathing difficulties after removal of the tube, infection risk at the site of the tracheostomy cannula, and possible need for reinsertion if decannulation fails.

DECAP-ICU Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from admission to the date when the patient quit the icu, through study completion, average of 6 to 12 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from admission to the date when the patient quit the icu, through study completion, average of 6 to 12 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and from admission to the date when the patient quit the icu, through study completion, average of 6 to 12 months. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Time to decannulation

Secondary outcome measures

Adverses effects

Decannulation failure

ICU readmission

+5 more

DECAP-ICU Trial Design

2Treatment groups

Experimental Treatment

Group I: Usual careExperimental Treatment1 Intervention

Usual care will mainly base on the capping trial.

Group II: Suction based protocolExperimental Treatment1 Intervention

Weaning protocol based on suctioning frequency. Once the weaning of mechanical ventilation, the patients in this arm will be on high-flow nasal canula. The canula will be remove if the decannulation conditions are met (if the patient require less than 2 aspirations in 8 hours for 24 consecutive hours)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Usual Care

1990

Completed Phase 4

~7700

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor

292 Previous Clinical Trials

69,391 Total Patients Enrolled

Media Library

Suctioning based protocol Clinical Trial Eligibility Overview. Trial Name: NCT05778682 — N/A

Tracheostomy Weaning Research Study Groups: Usual care, Suction based protocol

Tracheostomy Weaning Clinical Trial 2023: Suctioning based protocol Highlights & Side Effects. Trial Name: NCT05778682 — N/A

Suctioning based protocol 2023 Treatment Timeline for Medical Study. Trial Name: NCT05778682 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research require the inclusion of participants under 40 years of age?

"This medical research is searching for participants that are above the age of consent and not exceeding one century in age."

Answered by AI

Is this research open to all qualified participants?

"In order to join this medical trial, prospective participants must have had tracheostomy weaning and be between 18-100 years old. A maximum of 50 people will be enrolled into the study."

Answered by AI

Does this experiment have room for new participants?

"While initially posted on March 20th of 2023, the clinical trial listed in clinicaltrials.gov is no longer actively seeking patients at this time per the last update on March 9th that same year. Nevertheless, there are presently 1 other trials recruiting participants."

Answered by AI

Recent research and studies

JamaJournal

The Third International Consensus Definitions for Sepsis and Septic Shock (sepsis-3)

Singer, Mervyn, Clifford S. Deutschman, Christopher Warren Seymour, Manu Shankar-Hari, Djillali Annane, Michael Bauer, Rinaldo Bellomo, et al.. 2016. “The Third International Consensus Definitions for Sepsis and Septic Shock (sepsis-3)”. Jama. American Medical Association (AMA). doi:10.1001/jama.2016.0287.

BMC Medical Research MethodologyJournal

Estimating the Sample Mean and Standard Deviation from the Sample Size, Median, Range And/or Interquartile Range

Wan, Xiang, Wenqian Wang, Jiming Liu, and Tiejun Tong. 2014. “Estimating the Sample Mean and Standard Deviation from the Sample Size, Median, Range And/or Interquartile Range”. BMC Medical Research Methodology. Springer Science and Business Media LLC. doi:10.1186/1471-2288-14-135.

British Journal of AnaesthesiaJournal

Nasal High-flow Therapy Delivers Low Level Positive Airway Pressure

Parke, R., S. McGuinness, and M. Eccleston. 2009. “Nasal High-flow Therapy Delivers Low Level Positive Airway Pressure”. British Journal of Anaesthesia. Elsevier BV. doi:10.1093/bja/aep280.

clinicaltrials.govStudy